바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.78 No.4
Citation Share

A Case of Cryptogenic Organizing Pneumonia after Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2015, v.78 no.4, pp.469-472







& (2015). A Case of Cryptogenic Organizing Pneumonia after Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma. Tuberculosis & Respiratory Diseases, 78(4), 469-472.
  • Downloaded
  • Viewed
PDF Download

Abstract

Cryptogenic organizing pneumonia (COP) is an inflammatory lung disease involving the distal bronchioles, respiratory bronchioles, bronchiolar ducts, and alveolae. The etiology is usually unknown; however, there are several known causes and associated systemic diseases. Corticosteroid therapy is the best treatment option and the prognosis of COP is good, with recovery in up to 80% of patients. We described a patient with in-operable hepatocellular carcinoma (HCC) undergoing chemoembolization with doxorubicin in a drug-eluting bead (DEB). COP developed in the patient after chemoembolization but resolved spontaneously in several months.

keywords
Cryptogenic Organizing Pneumonia, Carcinoma, Hepatocellular, Chemoembolization, Therapeutic

Reference

1.

1. Cazzato S., Zompatori M., Baruzzi G., Schiattone ML., Burzi M., Rossi A. (2000), Bronchiolitis obliterans-organizing pneumonia: an Italian experience. Respir Med, 94,702-8.

2.

2. Chang J., Han J., Kim DW., Lee I., Lee KY., Jung S. (2002), Bronchiolitis obliterans organizing pneumonia: clinicopathologic review of a series of 45 Korean patients including rapidly progressive form. J Korean Med Sci, 17,179-86.

3.

3. Epler GR. (2011), Bronchiolitis obliterans organizing pneumonia, 25 years: a variety of causes, but what are the treatment options?, Expert Rev Respir Med, 5,353-61.

4.

4. Aladdin M., Ilyas M. (2011), Chemoembolization of hepatocellular carcinoma with drug-eluting beads complicated by interstitial pneumonitis. Semin Intervent Radiol, 28,218-21.

5.

5. Sacco R., Bargellini I., Bertini M., Bozzi E., Romano A., Petruzzi P. (2011), Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol, 22,1545-52.

6.

6. Shin SW. (2009), The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol, 10,425-34.

7.

7. Xia J., Ren Z., Ye S., Sharma D., Lin Z., Gan Y. (2006), Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. Eur J Radiol, 59,407-12.

8.

8. Ryu JH. (2010), Chemotherapy-induced pulmonary toxicity in lung cancer patients. J Thorac Oncol, 5,1313-4.

9.

9. Jacobs C., Slade M., Lavery B. (2002), Doxorubicin and BOOP. A possible near fatal association. Clin Oncol (R Coll Radiol), 14, 262.

10.

10. Stover DE., Milite F., Zakowski M. (2001), A newly recognized syndrome: radiation-related bronchiolitis obliterans and organizing pneumonia. A case report and literature review. Respiration, 68,540-4.

11.

11. Ogo E., Komaki R., Fujimoto K., Uchida M., Abe T., Nakamura K. (2008), A survey of radiation-induced bronchiolitis obliterans organizing pneumonia syndrome after breast-conserving therapy in Japan. Int J Radiat Oncol Biol Phys, 71,123-31.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy